Search results
Results from the WOW.Com Content Network
A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based treatment ...
In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...
However, with this treatment, the number of substantia nigra neurons decrease so it becomes less efficient. [2] These treatments try to reduce the symptoms of the patient focusing on increasing the production of dopamine but they do not cure the disease. The new treatments for PD are in clinical trials and most of them are centered on gene therapy.
Ali R. Rezai (born 1965) [1] is an Iranian-born American neurosurgeon and neuroscientist. [2] [3] His work and research has focused on neuromodulation treatments for patients with neurological and mental health conditions, [4] including neuromodulation techniques such as deep brain stimulation (DBS) through brain chip implants to treat Parkinson's disease tremors, obsessive–compulsive ...
The study, published in the Journal of Neurology, Neurosurgery and Psychiatry, looked at two groups – one group of about 143 patients with Parkinson's disease and active tai chi training, and ...
A notable impact on the pharmaceutical industry concerns the experimental Parkinson's drug prasinezumab, developed by Prothena Biosciences in collaboration with Roche. [12] A Phase II study reported in August 2022 found no statistically significant effect from the drug vs placebo on measures of Parkinson's disease progression. [ 12 ]
In January 2021 the FDA approved the first clinical trial for an investigational stem cell therapy to restore lost brain cells in people with advanced Parkinson's disease. [ 40 ] Healthy adult brains contain neural stem cells , which divide to maintain general stem-cell numbers, or become progenitor cells .
The first cell-based therapy investigated for Parkinson's disease utilized the adrenal medulla. The adrenal medulla is the innermost part of the adrenal gland and contains neural crest derived chromaffin cells which secrete norepinephrine , epinephrine and to a far lesser extent dopamine into the blood.